Table 1. Clinicopathological features of previously reported cases of MELTVR and the present case.

ER: estrogen receptor, PgR: progesterone receptor, EMA: epithelial membrane antigen, α-SMA: α smooth muscle actin, CK: Cytokeratin , AR: androgen receptor, +: positive, -: negative, NR: not reported

Author	Age	Clinical presentation	Tumor size	Histological findings	Immunohistochemistry		SMARCB1	Treatment	Margin	Outcome
Yoshida et al. [1]	24–70	Vulvar mass/nodule	Variable	Spindle to epithelioid cells with myxoid and hypercellular areas	ER + PgR + EMA +	variable α-SMA	Lost	Surgical excision	Variable	Mostly favorable (1-172 months)
Liu et al. [2]	43	Vulvar mass	3.5 cm	Myxoid and solid components with spindle/plasmacytoid cells			Lost	Wide local excision	NR	No recurrence
Urakami et al. [3]	54	Vulvar tumor after inguinal tumor excision	4 cm	Lobulated tumor with myxoid stroma	ER + PgR +		Lost	Surgical excision	Negative	No recurrence (10 months)
Aminimoghaddam et al. [4]	46	Subcutaneous vulvar nodules with recent enlargement and discomfort; mass involving the right labia majora and mons pubis	10 cm	Myxoid mesenchymal tissues. A mild to moderate atypia. No mitosis or necrosis		Vimentin +	Lost	Surgical resection	NR	Recurrence (36 months)
Kamboj et al. [5]	47	A mobile swelling in the subcutaneous region of right labia majora	3 cm	Solid sheets of cells with a predominant epithelioid to rhabdoid morphology and focal areas of spindling	ER + EMA +	CK -	Lost	Surgical resection	NR	No recurrence (6 months)
Present case	23	Myxoid and hypercellular areas with spindle to plasmacytoid cells, necrosis, and mitotic activity	4.5 cm	Myxoid and hypercellular areas with spindle to plasmacytoid cells, necrosis, and mitotic activity	ER + PgR + EMA +	AR +	Lost	Surgical excision	Negative	No recurrence (3 months)